info@carbon-zero.uk | BOOK A CONSULTATION

Major Pharma Client – Carbon Assessment and Reduction Plan, and Double Materiality (ESRS) reporting

Client: Major Pharmaceutical Manufacturer

Sector: Pharmaceutical Manufacturing

Services: Carbon Assessment | NHS Evergreen support | ESRS Double Materiality report.

This company are part of the global organisation providing medicines to manage and treat blood clotting issues. As part of their sustainability commitments, they are required to meet NHS England Evergreen Net Zero reduction targets.

They engaged Carbon Zero to advance progress of their carbon awareness and a reduction program and improve their status on the NHS Evergreen platform.

Objectives

Independently assess operations carbon emissions
Identify opportunities for reduction
Complete ESRS Double Materiality report to align with EU CSRD directive and report on the most material impacts, risks and opportunities for the business.

Results

Delivering a comprehensive carbon assessment and updated Carbon Reduction Plan.
Comprehensive ESRS Double Materiality Report and Matrix identifying their most relevant impacts, risks, and opportunities, based on both impact and financial materiality.

Value To Client

Through Carbon Zero’s strategic support, this client has:

Secured NHS Evergreen Level 2 attainment, confirming their commitment to climate change and aligning with the NHS Net Zero targets.
A clear understanding of positive and negative impacts and opportunities across entire value chain
Priority business actions going forward for company resilience
Disclosure requirements so company reporting can comply with CSRD